Recombinant HSP65 protein (ab92416)
Key features and details
- Expression system: Escherichia coli
- Purity: > 90% SDS-PAGE
- Endotoxin level:
- Active: Yes
- Suitable for: WB, Functional Studies, SDS-PAGE
-
Product name
Recombinant HSP65 protein
See all HSP65 proteins and peptides -
Biological activity
This product does not contain GroEL. -
Purity
> 90 % SDS-PAGE.
ab92416 is purified by Multi-step chromatography -
Endotoxin level
Expression system
Escherichia coliProtein length
Full length proteinAnimal free
NoNature
Recombinant-
Species
Mycobacterium bovis
Specifications
Our Abpromise guarantee covers the use of ab92416 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
Western blot
Functional Studies
SDS-PAGE
-
Form
Liquid -
Additional notes
This product does not contain GroEL. -
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
Constituents: 0.01999% Monobasic dihydrogen potassium phosphate, 0.11445% Dibasic monohydrogen sodium phosphate, 0.02025% Potassium chloride, 0.8004% Sodium chloride
This product is an active protein and may elicit a biological response in vivo, handle with caution.
General Info
-
Relevance
HSP65 is a member of the HSP60 family of heat shock proteins isolated from Mycobacterium bovis BCG. HSP65 from M. bovis is identical to that of M. tuberculosis, and similar to that of M. leprae, two highly pathogenic strains of mycobacterium. HSP65 is the immunodominant antigen during mycobacterial infection and vaccination, and has been linked to the development of autoimmune adjuvant arthritis in rats.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
References (1)
ab92416 has been referenced in 1 publication.
- Kim BJ et al. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine. Front Immunol 9:643 (2018). PubMed: 29636755